• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

复杂感染中活检组织的微生物群分析:通过宏基因组下一代测序进行诊断和预后分析。

Microbiota profiling from biopsied tissues in complex infections: a diagnostic and prognostic analysis through metagenomic next-generation sequencing.

作者信息

Song Tiange, Yin Lin, Zhou Xiaoli, Tao Xiaoyan, Tie Dandan, Zhang Jie, Jiang Li

机构信息

Department of Laboratory Medicine, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, Sichuan, China.

Sichuan Provincial Key Laboratory for Human Disease Gene Study, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, Sichuan, China.

出版信息

Front Cell Infect Microbiol. 2025 May 8;15:1567981. doi: 10.3389/fcimb.2025.1567981. eCollection 2025.

DOI:10.3389/fcimb.2025.1567981
PMID:40406519
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12095327/
Abstract

BACKGROUND

Infectious diseases that require tissue biopsy are usually more difficult to diagnose through conventional microbiological tests (CMT), and knowledge of the infection microbiota pattern from biopsied tissues remains incomplete. Our study aimed to investigate the diagnostic and prognostic value of metagenomic next-generation sequencing (mNGS), characterize the microbiota profile from biopsied tissues, and examine its relationship with clinical outcomes.

METHODS

This retrospective cohort study included 110 patients who underwent tissue biopsy and sent both mNGS and CMT due to suspected complex infection. Microbiota patterns were illustrated via unsupervised hierarchical clustering analysis. Multivariate regression analysis was used to investigate the effect measures.

RESULTS

The sensitivity of mNGS was significantly higher than that of CMT regarding bacteria (87.23% 40.43%, P=0.01), viruses (100% 5.56%, P<0.001), and fungi (87.5% 28.6%, P=0.04). Polymicrobial infection accounted for 45.2% (33/73) of the infection samples. In skeletal articular biopsied tissues, Staphylococcus presented the highest mean abundance among different species of bacteria (21.2% of all bacterial reads, standard deviation (SD) 38.9). Anaerobic bacteria (24.0%, SD 25.9) represented the most common bacteria in biopsied tissue from the lung or mediastinum. The presence of gram-negative bacteria (adjusted OR 5.21, 95% CI 1.39-19.43, P=0.01), Enterobacteriaceae (adjusted OR 5.71, 95% CI 1.17-28.03, P=0.03) and Staphylococcus (adjusted OR 8.64, 95% CI 1.95-38.34, P=0.005) was associated with an increased risk of treatment failure. Early mNGS sampling within 7 days after admission was associated with a significantly decreased risk of all-cause mortality (HR 0.18, 95% CI 0.04-0.94; P=0.04), treatment failure (OR 0.17, 95% CI 0.05-0.66; P=0.01), and increased probability of clinical resolution (OR 3.03, 95% CI 1.24-7.40; P=0.01).

CONCLUSION

mNGS demonstrates significant diagnostic and prognostic efficacy in patients undergoing tissue biopsy for suspected complex infections. The presence of Gram-negative bacteria, Enterobacteriaceae, and Staphylococcus is associated with a higher probability of treatment failure, which underscores the advantage of using mNGS to guide more aggressive antibiotic strategies.

摘要

背景

需要组织活检的感染性疾病通常通过传统微生物检测(CMT)更难诊断,并且来自活检组织的感染微生物群模式的相关知识仍不完整。我们的研究旨在调查宏基因组下一代测序(mNGS)的诊断和预后价值,描绘活检组织中的微生物群特征,并检查其与临床结果的关系。

方法

这项回顾性队列研究纳入了110例因疑似复杂感染而接受组织活检并同时进行mNGS和CMT检测的患者。通过无监督层次聚类分析展示微生物群模式。使用多变量回归分析来研究效应指标。

结果

在细菌(87.23%对40.43%,P = 0.01)、病毒(100%对5.56%,P < 0.001)和真菌(87.5%对28.6%,P = 0.04)方面,mNGS的敏感性显著高于CMT。混合微生物感染占感染样本的45.2%(33/73)。在骨骼关节活检组织中,葡萄球菌在不同细菌种类中平均丰度最高(占所有细菌读数的21.2%,标准差(SD)38.9)。厌氧菌(24.0%,SD 25.9)是肺或纵隔活检组织中最常见的细菌。革兰氏阴性菌(校正OR 5.21,95%CI 1.39 - 19.43,P = 0.01)、肠杆菌科(校正OR 5.71,95%CI 1.17 - 28.03,P = 0.03)和葡萄球菌(校正OR 8.64,95%CI 1.95 - 38.34,P = 0.005)的存在与治疗失败风险增加相关。入院后7天内尽早进行mNGS采样与全因死亡率显著降低(HR 0.18,95%CI 0.

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1071/12095327/53acb9d8ff41/fcimb-15-1567981-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1071/12095327/5660639b6577/fcimb-15-1567981-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1071/12095327/a53784255866/fcimb-15-1567981-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1071/12095327/2440f852a011/fcimb-15-1567981-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1071/12095327/53acb9d8ff41/fcimb-15-1567981-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1071/12095327/5660639b6577/fcimb-15-1567981-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1071/12095327/a53784255866/fcimb-15-1567981-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1071/12095327/2440f852a011/fcimb-15-1567981-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1071/12095327/53acb9d8ff41/fcimb-15-1567981-g004.jpg

相似文献

1
Microbiota profiling from biopsied tissues in complex infections: a diagnostic and prognostic analysis through metagenomic next-generation sequencing.复杂感染中活检组织的微生物群分析:通过宏基因组下一代测序进行诊断和预后分析。
Front Cell Infect Microbiol. 2025 May 8;15:1567981. doi: 10.3389/fcimb.2025.1567981. eCollection 2025.
2
Application of metagenomic next-generation sequencing in pathogen detection of lung infections.宏基因组下一代测序在肺部感染病原体检测中的应用。
Front Cell Infect Microbiol. 2025 May 1;15:1513603. doi: 10.3389/fcimb.2025.1513603. eCollection 2025.
3
Detection of Pulmonary Infectious Pathogens From Lung Biopsy Tissues by Metagenomic Next-Generation Sequencing.宏基因组下一代测序检测肺活检组织中的肺部感染病原体。
Front Cell Infect Microbiol. 2018 Jun 25;8:205. doi: 10.3389/fcimb.2018.00205. eCollection 2018.
4
Application of the second-generation sequencing technology of metagenomics in the detection of pathogens in respiratory patients.宏基因组二代测序技术在呼吸道感染患者病原体检测中的应用。
J Microbiol Methods. 2024 Oct;225:107021. doi: 10.1016/j.mimet.2024.107021. Epub 2024 Aug 13.
5
A single-center, retrospective study of hospitalized patients with lower respiratory tract infections: clinical assessment of metagenomic next-generation sequencing and identification of risk factors in patients.一项关于下呼吸道感染住院患者的单中心回顾性研究:宏基因组下一代测序的临床评估及患者风险因素的识别。
Respir Res. 2024 Jun 20;25(1):250. doi: 10.1186/s12931-024-02887-y.
6
Metagenomic next-generation sequencing for lung cancer low respiratory tract infections diagnosis and characterizing microbiome features.宏基因组下一代测序用于肺癌下呼吸道感染的诊断及微生物群特征分析。
Front Cell Infect Microbiol. 2025 Jan 23;14:1518199. doi: 10.3389/fcimb.2024.1518199. eCollection 2024.
7
Diagnostic value of metagenomic next-generation sequencing using bronchoalveolar lavage fluid samples for pathogen detection in children with severe or refractory pneumonia.基于支气管肺泡灌洗液体样本的宏基因组二代测序在儿童重症或难治性肺炎病原体检测中的诊断价值
Microbiol Spectr. 2025 Mar 4;13(3):e0108724. doi: 10.1128/spectrum.01087-24. Epub 2025 Feb 4.
8
The diagnostic value of bronchoalveolar lavage fluid metagenomic next-generation sequencing in critically ill patients with respiratory tract infections.支气管肺泡灌洗液体宏基因组下一代测序在重症呼吸道感染患者中的诊断价值
Microbiol Spectr. 2024 Aug 6;12(8):e0045824. doi: 10.1128/spectrum.00458-24. Epub 2024 Jun 25.
9
The application prospect of metagenomic next-generation sequencing technology in diagnosing suspected lower respiratory tract infections.宏基因组新一代测序技术在诊断疑似下呼吸道感染中的应用前景
Front Cell Infect Microbiol. 2025 Apr 16;15:1494638. doi: 10.3389/fcimb.2025.1494638. eCollection 2025.
10
Metagenomic next-generation sequencing targeted and metagenomic next-generation sequencing for pulmonary infection in HIV-infected and non-HIV-infected individuals.宏基因组下一代测序靶向检测与宏基因组下一代测序在 HIV 感染和非 HIV 感染个体肺部感染中的应用。
Front Cell Infect Microbiol. 2024 Aug 19;14:1438982. doi: 10.3389/fcimb.2024.1438982. eCollection 2024.

本文引用的文献

1
Epidemiological and clinical overview of the 2024 Oropouche virus disease outbreaks, an emerging/re-emerging neurotropic arboviral disease and global public health threat.2024年奥罗普切病毒病疫情的流行病学和临床概述,一种新出现/再次出现的嗜神经性虫媒病毒病及全球公共卫生威胁。
J Med Virol. 2024 Sep;96(9):e29897. doi: 10.1002/jmv.29897.
2
Assembled mixed co-cultures for emerging pollutant removal using native microorganisms from sewage sludge.利用污水污泥中的天然微生物组装混合共培养物以去除新兴污染物。
Chemosphere. 2023 Feb;313:137472. doi: 10.1016/j.chemosphere.2022.137472. Epub 2022 Dec 7.
3
TTV viral load as a predictor of antibody response to SARS COV-2 vaccination.
TTV 病毒载量作为 SARS-CoV-2 疫苗接种后抗体应答的预测指标。
J Heart Lung Transplant. 2023 Feb;42(2):143-144. doi: 10.1016/j.healun.2022.10.025. Epub 2022 Nov 6.
4
Epidemiology and outcome of anaerobic bacteremia in a tertiary hospital.三级医院厌氧性菌菌血症的流行病学和结局。
Eur J Intern Med. 2022 Nov;105:63-68. doi: 10.1016/j.ejim.2022.08.024. Epub 2022 Aug 31.
5
Utility of Metagenomic Next-Generation Sequencing for Etiological Diagnosis of Patients with Sepsis in Intensive Care Units.宏基因组下一代测序在重症监护病房脓毒症患者病因诊断中的应用。
Microbiol Spectr. 2022 Aug 31;10(4):e0074622. doi: 10.1128/spectrum.00746-22. Epub 2022 Jul 21.
6
Metagenomic Analysis Reveals High Abundance of Torque Teno Mini Virus in the Respiratory Tract of Children with Acute Respiratory Illness.宏基因组分析揭示急性呼吸道疾病患儿呼吸道中 Torque Teno 微小病毒的高丰度。
Viruses. 2022 May 3;14(5):955. doi: 10.3390/v14050955.
7
Application of mNGS in the Etiological Analysis of Lower Respiratory Tract Infections and the Prediction of Drug Resistance.mNGS 在呼吸道感染病因分析及耐药预测中的应用
Microbiol Spectr. 2022 Feb 23;10(1):e0250221. doi: 10.1128/spectrum.02502-21. Epub 2022 Feb 16.
8
The Diagnostic Value of Metagenomic Next-Generation Sequencing in Lower Respiratory Tract Infection.宏基因组下一代测序在下呼吸道感染中的诊断价值。
Front Cell Infect Microbiol. 2021 Sep 9;11:694756. doi: 10.3389/fcimb.2021.694756. eCollection 2021.
9
Enhanced Virus Detection and Metagenomic Sequencing in Patients with Meningitis and Encephalitis.在脑膜炎和脑炎患者中增强病毒检测和宏基因组测序。
mBio. 2021 Aug 31;12(4):e0114321. doi: 10.1128/mBio.01143-21.
10
Clinical Evaluation of an Improved Metagenomic Next-Generation Sequencing Test for the Diagnosis of Bloodstream Infections.一种改进的宏基因组下一代测序检测用于血流感染诊断的临床评估
Clin Chem. 2021 Aug 5;67(8):1133-1143. doi: 10.1093/clinchem/hvab061.